首页 > 最新文献

Gynecology and Obstetrics Clinical Medicine最新文献

英文 中文
Impact of community strategy package on uptake of reproductive tract infections health services among young street females in the municipality of Eldoret, Kenya 社区一揽子战略对肯尼亚埃尔多雷特市年轻街头女性接受生殖道感染卫生服务的影响
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.009
C Violet Maritim , Anthony Wanyoro , John Maingi , Jackim Nyamari , Murima Ng'ang'a

Background

Despite the intervention of free medical care services for street children by a dedicated clinic in Eldoret municipality, health care service of young street females (YSFs) is still deficient. The present study aimed to evaluate the impact of the community strategy package on the uptake of reproductive tract infections (RTI) health services among the target population.

Materials and methods

A pre-test-post-test quasi-experimental with a qualitative and quantitative approach was applied among the YSFs aged 10–24 years. The study used structured questionnaires and key informant interviews to collect data from the respondents.

Results

The study enrolled a total of 77 young street females in Eldoret municipality. A significantly higher proportion of respondents reportedly first sought treatment for RTI at a health facility after the implementation of the community strategy package (97.1%) when compared to the proportion of respondents who first sought treatment at a health facility in the pre-intervention phase (51.0%)(p<0.001). Early seeking of treatment improved significantly after the introduction of the intervention; 72.0% and 94.1% of the respondents sought treatment early during the pre-intervention and post-intervention phase, respectively (p ​= ​0.011).

Conclusion

The study recommends the adoption of the community strategy as an intervention to increase the uptake of RTIs health services and promotion of the reproductive health of young street females.

背景尽管埃尔多雷特市的一家专门诊所为街头儿童提供了免费医疗服务,但街头女青年的保健服务仍然不足。本研究旨在评估社区一揽子战略对目标人群接受生殖道感染(RTI)保健服务的影响。材料与方法采用定性与定量相结合的准实验方法对10 ~ 24岁的青年青少年进行测试。该研究使用结构化问卷和关键信息访谈来收集受访者的数据。结果本研究共招募了埃尔多雷特市的77名年轻街头女性。据报告,与在干预前阶段首先在卫生机构寻求治疗的应答者比例(51.0%)相比,在社区一揽子战略实施后,应答者首次在卫生机构寻求RTI治疗的比例(97.1%)要高得多(p<0.001)。干预措施实施后,早期寻求治疗的情况显著改善;干预前和干预后早期寻求治疗的比例分别为72.0%和94.1% (p = 0.011)。结论本研究建议采用社区策略作为一种干预措施,以提高街头年轻女性对rti保健服务的接受程度,促进她们的生殖健康。
{"title":"Impact of community strategy package on uptake of reproductive tract infections health services among young street females in the municipality of Eldoret, Kenya","authors":"C Violet Maritim ,&nbsp;Anthony Wanyoro ,&nbsp;John Maingi ,&nbsp;Jackim Nyamari ,&nbsp;Murima Ng'ang'a","doi":"10.1016/j.gocm.2023.01.009","DOIUrl":"10.1016/j.gocm.2023.01.009","url":null,"abstract":"<div><h3>Background</h3><p>Despite the intervention of free medical care services for street children by a dedicated clinic in Eldoret municipality, health care service of young street females (YSFs) is still deficient. The present study aimed to evaluate the impact of the community strategy package on the uptake of reproductive tract infections (RTI) health services among the target population.</p></div><div><h3>Materials and methods</h3><p>A pre-test-post-test quasi-experimental with a qualitative and quantitative approach was applied among the YSFs aged 10–24 years. The study used structured questionnaires and key informant interviews to collect data from the respondents.</p></div><div><h3>Results</h3><p>The study enrolled a total of 77 young street females in Eldoret municipality. A significantly higher proportion of respondents reportedly first sought treatment for RTI at a health facility after the implementation of the community strategy package (97.1%) when compared to the proportion of respondents who first sought treatment at a health facility in the pre-intervention phase (51.0%)(<em>p</em><0.001). Early seeking of treatment improved significantly after the introduction of the intervention; 72.0% and 94.1% of the respondents sought treatment early during the pre-intervention and post-intervention phase, respectively (<em>p ​= ​0.011</em>).</p></div><div><h3>Conclusion</h3><p>The study recommends the adoption of the community strategy as an intervention to increase the uptake of RTIs health services and promotion of the reproductive health of young street females.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 60-64"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45872951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Incidental bilateral ovarian paraganglioma of uterine fibroid with widespread adenomyosis: A case report” [Gynecol Obstet Clin Med 2 (4) (2022) 208–210] 更正“子宫肌瘤伴广泛性子宫腺肌症的双侧卵巢副神经节瘤:一例病例报告”[Gynecol Obstet Clin Med 2(4)(2022)208-210]
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.02.001
Zaibun Nisa, Dhafir Al-Okati, Olugbenga Duroshola, Deepali Bhatte
{"title":"Corrigendum to “Incidental bilateral ovarian paraganglioma of uterine fibroid with widespread adenomyosis: A case report” [Gynecol Obstet Clin Med 2 (4) (2022) 208–210]","authors":"Zaibun Nisa,&nbsp;Dhafir Al-Okati,&nbsp;Olugbenga Duroshola,&nbsp;Deepali Bhatte","doi":"10.1016/j.gocm.2023.02.001","DOIUrl":"10.1016/j.gocm.2023.02.001","url":null,"abstract":"","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Page 70"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43349873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytogenetic analysis and family research for two cases of chromosome 6 microduplication and chromosome 9 microdeletion: Different clinical manifestations 6号染色体微重复与9号染色体微缺失2例临床表现的细胞遗传学分析与家族研究
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.003
Lin Zhang, Mei Hong Ren, Guining Song, Xuexia Liu, Yanhui Li, Chengling Zhang, Xiaohong Zhang
{"title":"Cytogenetic analysis and family research for two cases of chromosome 6 microduplication and chromosome 9 microdeletion: Different clinical manifestations","authors":"Lin Zhang,&nbsp;Mei Hong Ren,&nbsp;Guining Song,&nbsp;Xuexia Liu,&nbsp;Yanhui Li,&nbsp;Chengling Zhang,&nbsp;Xiaohong Zhang","doi":"10.1016/j.gocm.2023.01.003","DOIUrl":"10.1016/j.gocm.2023.01.003","url":null,"abstract":"","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 65-69"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47313008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update of sentinel lymph node mapping assessment in endometrial cancer 子宫内膜癌症前哨淋巴结定位评估的最新进展
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.005
Se Ik Kim, Jae-Weon Kim

Endometrial cancer is the most common gynecologic malignancy in developed countries. Pathologic confirmation of lymph node metastasis is important for risk stratification and the administration of adjuvant treatments. Therefore, comprehensive, systematic lymphadenectomy has been routinely performed but has been associated with various morbidities. Meanwhile, the concept of sentinel lymph node (SLN) mapping and biopsy has emerged and is now accepted as an alternative to conventional systematic lymphadenectomy in early-stage endometrial cancer. For better management of endometrial cancer, we conducted a literature review to summarize the role and diagnostic accuracy of the SLN mapping strategy in endometrial cancer. Evidence from the monumental and recent literature and ongoing clinical trials will be introduced.

子宫内膜癌是发达国家最常见的妇科恶性肿瘤。淋巴结转移的病理确认对于危险分层和辅助治疗的管理是重要的。因此,全面、系统的淋巴结切除术已成为常规手术,但与各种发病率相关。与此同时,前哨淋巴结(SLN)定位和活检的概念已经出现,现在被认为是早期子宫内膜癌常规系统性淋巴结切除术的替代方法。为了更好地治疗子宫内膜癌,我们进行了一项文献综述,总结了SLN定位策略在子宫内膜癌中的作用和诊断准确性。从不朽的和最近的文献和正在进行的临床试验的证据将被介绍。
{"title":"Update of sentinel lymph node mapping assessment in endometrial cancer","authors":"Se Ik Kim,&nbsp;Jae-Weon Kim","doi":"10.1016/j.gocm.2023.01.005","DOIUrl":"10.1016/j.gocm.2023.01.005","url":null,"abstract":"<div><p>Endometrial cancer is the most common gynecologic malignancy in developed countries. Pathologic confirmation of lymph node metastasis is important for risk stratification and the administration of adjuvant treatments. Therefore, comprehensive, systematic lymphadenectomy has been routinely performed but has been associated with various morbidities. Meanwhile, the concept of sentinel lymph node (SLN) mapping and biopsy has emerged and is now accepted as an alternative to conventional systematic lymphadenectomy in early-stage endometrial cancer. For better management of endometrial cancer, we conducted a literature review to summarize the role and diagnostic accuracy of the SLN mapping strategy in endometrial cancer. Evidence from the monumental and recent literature and ongoing clinical trials will be introduced.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 1-6"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41739147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions 高危人乳头瘤病毒基因分型及病毒载量在宫颈癌及癌前病变中的临床意义
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.001
Pingping Su , Jincheng Ma , Lirui Yu , Shuting Tang , Pengming Sun

Persistent infections with specific high-risk human papillomavirus (HR-HPV) strains are the leading cause of cervical cancer and precancerous lesions. HPV-16 and HPV-18 are associated with more than 70% of cervical cancer. However, with recent widespread vaccination efforts against cervical cancer, the infection rates of HPV-16 and HPV-18 have decreased across all age groups, while the infection rates of other HR-HPV strains have increased. The non-16/18 HR-HPV strains play an important role in cervical lesions. These strains can be identified with extended genotyping, and the 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines recommended an HPV-based testing to assess the risk of cervical disease in patients. We reviewed and analyzed the clinical benefits of applying extended HR-HPV genotyping, which was published by the International Agency for Research on Cancer (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), to cervical cancer screening. This review concluded that cervical cancer screening needs to include extended HR-HPV genotyping. The examination of extended HR-HPV genotyping in cervical intraepithelial lesions and cervical cancers can help guide clinical practices.

特定高危人乳头瘤病毒(HR-HPV)株持续感染是宫颈癌和癌前病变的主要原因。HPV-16和HPV-18与超过70%的宫颈癌有关。然而,随着最近广泛开展宫颈癌疫苗接种工作,HPV-16和HPV-18的感染率在所有年龄组中都有所下降,而其他HR-HPV毒株的感染率有所上升。非16/18 HR-HPV株在宫颈病变中起重要作用。这些菌株可以通过扩展基因分型来识别,2019年美国阴道镜和宫颈病理学会(ASCCP)指南建议采用基于hpv的检测来评估患者宫颈疾病的风险。我们回顾并分析了国际癌症研究机构发布的扩展HR-HPV基因分型(HPV-16、18、31、33、35、39、45、51、52、56、58、59、66和68)应用于宫颈癌筛查的临床益处。这篇综述的结论是宫颈癌筛查需要包括扩展的HR-HPV基因分型。宫颈上皮内病变和宫颈癌的扩展HR-HPV基因分型检查可以帮助指导临床实践。
{"title":"Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions","authors":"Pingping Su ,&nbsp;Jincheng Ma ,&nbsp;Lirui Yu ,&nbsp;Shuting Tang ,&nbsp;Pengming Sun","doi":"10.1016/j.gocm.2023.01.001","DOIUrl":"10.1016/j.gocm.2023.01.001","url":null,"abstract":"<div><p>Persistent infections with specific high-risk human papillomavirus (HR-HPV) strains are the leading cause of cervical cancer and precancerous lesions. HPV-16 and HPV-18 are associated with more than 70% of cervical cancer. However, with recent widespread vaccination efforts against cervical cancer, the infection rates of HPV-16 and HPV-18 have decreased across all age groups, while the infection rates of other HR-HPV strains have increased. The non-16/18 HR-HPV strains play an important role in cervical lesions. These strains can be identified with extended genotyping, and the 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines recommended an HPV-based testing to assess the risk of cervical disease in patients. We reviewed and analyzed the clinical benefits of applying extended HR-HPV genotyping, which was published by the International Agency for Research on Cancer (HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), to cervical cancer screening. This review concluded that cervical cancer screening needs to include extended HR-HPV genotyping. The examination of extended HR-HPV genotyping in cervical intraepithelial lesions and cervical cancers can help guide clinical practices.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 22-29"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45406191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Advances in diagnosis, clinical management and molecular characterization of ovarian Brenner tumors 卵巢Brenner肿瘤的诊断、临床治疗和分子特征研究进展
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.007
Valentina Zanfagnin , Tiffany Lee , Chengquan Zhao , Tiannan Wang

Brenner tumors is a very uncommon ovarian epithelial neoplasm, morphologically resembling the transitional cell neoplasm of urinary tract. It is further classified into three subtypes as a disease spectrum based on histological examination and tumorigenesis: benign Brenner tumors, borderline Brenner tumors (BBTs), and malignant Brenner tumors (MBTs). The etiology of these tumors is not well understood, and literature is limited due to the rarity of this entity, but recent advances, particularly in molecular alterations, have emerged. The scope of this review is to provide an update on the clinical, histopathological, and most recently, molecular characterizations of ovarian Brenner tumors.

勃勒纳瘤是一种非常罕见的卵巢上皮性肿瘤,形态类似于泌尿道的移行细胞瘤。根据组织学检查和肿瘤发生进一步将其分为三种亚型:良性勃勒纳瘤、交界性勃勒纳瘤(BBTs)和恶性勃勒纳瘤(mbt)。这些肿瘤的病因尚不清楚,由于这种实体的罕见性,文献有限,但最近的进展,特别是在分子改变方面,已经出现。这篇综述的范围是提供一个最新的临床,组织病理学,和最近,卵巢布伦纳瘤的分子特征。
{"title":"Advances in diagnosis, clinical management and molecular characterization of ovarian Brenner tumors","authors":"Valentina Zanfagnin ,&nbsp;Tiffany Lee ,&nbsp;Chengquan Zhao ,&nbsp;Tiannan Wang","doi":"10.1016/j.gocm.2023.01.007","DOIUrl":"10.1016/j.gocm.2023.01.007","url":null,"abstract":"<div><p>Brenner tumors is a very uncommon ovarian epithelial neoplasm, morphologically resembling the transitional cell neoplasm of urinary tract. It is further classified into three subtypes as a disease spectrum based on histological examination and tumorigenesis: benign Brenner tumors, borderline Brenner tumors (BBTs), and malignant Brenner tumors (MBTs). The etiology of these tumors is not well understood, and literature is limited due to the rarity of this entity, but recent advances, particularly in molecular alterations, have emerged. The scope of this review is to provide an update on the clinical, histopathological, and most recently, molecular characterizations of ovarian Brenner tumors.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 18-21"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47543237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of assisted reproductive technology and uterine leiomyoma on pregnancy outcomes in women with adenomyosis 辅助生殖技术和子宫平滑肌瘤对妊娠结局的影响
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.008
Yi-Ling Wang , Zhao Tian , Xiao-Hong Chang, Hong-Lan Zhu, Heng Cui

Aim

To assess whether adverse pregnancy outcomes in women with adenomyosis are different according to the method of conception and the concurrent of uterine leiomyoma (UL).

Methods

We performed a retrospective study. Fifty-three singleton pregnancy cases complicated with adenomyosis were included in this study. In the study group, 15 women became pregnant with assisted reproductive technology (ART) and 21 women combined with UL. Pregnancy outcomes were compared between ART and non-ART, UL and non-UL groups.

Results

The prevalence for such complications as hypertensive disorder complicating pregnancy (HDCP)and postpartum hemorrhage (PPH)were significantly higher in the women conceived by ART (33.3% vs. 5.3%, P ​= ​0.023) and (53.3% vs. 23.7%, P ​= ​0.037),respectively. And women concurrent with UL of which the diameter≥4 ​cm were more likely to have severe PPH (44.4% vs. 0%, P ​= ​0.021).

Conclusion

ART may increase the risk of adverse pregnancy outcomes such as HDCP and PPH in women with adenomyosis and UL of which the diameter≥4 ​cm may further increase the risk of severe PPH.

目的探讨子宫腺肌病患者的不良妊娠结局是否因受孕方式及并发子宫平滑肌瘤(UL)的不同而不同。方法采用回顾性研究。本研究纳入53例单胎妊娠合并子宫腺肌病的病例。在研究组中,15名妇女通过辅助生殖技术(ART)怀孕,21名妇女联合使用UL。比较ART组和非ART组、UL组和非UL组的妊娠结局。结果ART妊娠组妊娠期高血压疾病(HDCP)和产后出血(PPH)发生率分别为33.3%比5.3% (P = 0.023)和53.3%比23.7% (P = 0.037)。合并UL且直径≥4 cm的女性发生严重PPH的可能性更大(44.4%比0%,P = 0.021)。结论art可增加子宫腺肌症和子宫内膜直径≥4 cm的子宫内膜炎患者发生HDCP和PPH等不良妊娠结局的风险,进一步增加重度PPH的发生风险。
{"title":"Influence of assisted reproductive technology and uterine leiomyoma on pregnancy outcomes in women with adenomyosis","authors":"Yi-Ling Wang ,&nbsp;Zhao Tian ,&nbsp;Xiao-Hong Chang,&nbsp;Hong-Lan Zhu,&nbsp;Heng Cui","doi":"10.1016/j.gocm.2023.01.008","DOIUrl":"10.1016/j.gocm.2023.01.008","url":null,"abstract":"<div><h3>Aim</h3><p>To assess whether adverse pregnancy outcomes in women with adenomyosis are different according to the method of conception and the concurrent of uterine leiomyoma (UL).</p></div><div><h3>Methods</h3><p>We performed a retrospective study. Fifty-three singleton pregnancy cases complicated with adenomyosis were included in this study. In the study group, 15 women became pregnant with assisted reproductive technology (ART) and 21 women combined with UL. Pregnancy outcomes were compared between ART and non-ART, UL and non-UL groups.</p></div><div><h3>Results</h3><p>The prevalence for such complications as hypertensive disorder complicating pregnancy (HDCP)and postpartum hemorrhage (PPH)were significantly higher in the women conceived by ART (33.3% vs. 5.3%, P ​= ​0.023) and (53.3% vs. 23.7%, P ​= ​0.037),respectively. And women concurrent with UL of which the diameter≥4 ​cm were more likely to have severe PPH (44.4% vs. 0%, P ​= ​0.021).</p></div><div><h3>Conclusion</h3><p>ART may increase the risk of adverse pregnancy outcomes such as HDCP and PPH in women with adenomyosis and UL of which the diameter≥4 ​cm may further increase the risk of severe PPH.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 56-59"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44903893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of molecular classification in 52 endometrial cancer and atypical hyperplasia patients receiving fertility-sparing treatment 52例癌症和不典型增生患者保留受精治疗的分子分类特征
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2023.01.006
Yiqin Wang , Nan Kang , Liwei Li , Zhiqi Wang , Rong Zhou , Danhua Shen , Jianliu Wang

Objective

To investigate the molecular classification of endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) patients treated with fertility-sparing treatment (FST), and its relationship with clinicopathological factors and treatment efficacy. Methods: A total of 52 ​EC and AEH patients who received FST and molecular classification tested by next generation sequencing in Peking University People's Hospital from June 2020 to December 2022, were retrospectively collected. We analyzed the relationship between molecular classification and clinicopathological factors and treatment outcomes.

Results

(1) Of the 52 patients, including 46 ​EC and 6 AEH patients, 42 (80.8%) achieved complete remission (CR) after FST, with a median time to achieve CR of 9 months. Ten cases (23.8%) had recurrence. (2) Patients were distributed into 4 molecular subgroups as 39 cases (75%) of copy number low (CNL) , 7 cases (13.5%) of microsatellite instability-high (MSI-H) , 4 cases (7.7%) of POLE mutations (POLEmut), and 2 cases (3.8%) of copy number high (CNH). Patients with MSI-H subgroup had more family history of tumor (6/7), more with loss of expression of mismatch repair (MMR) protein (7/7), and higher expression level of Ki-67 (3/3). (3) Patients with MSI-H subgroup had the lowest CR rate at 6 months (0/7, P ​= ​0.014), and survival analysis showed that such patients were less likely to achieve CR than those with CNL (P ​= ​0.022). For CNL patients, median 6-month CR rate was 40.6%. In addition, CR was obtained in 3 (3/4) POLEmut patients and 2 (2/2) CNH patients, respectively.

Conclusions

Molecular classification relates with the treatment response in patients with EC and AEH receiving FST. Patients with MSI-H subgroup have poor treatment efficacy, and patients with CNL need to be further divided to predict treatment benefit. There are also a few successful cases in POLEmut and CNH subtgroups, which needs further research.

目的探讨保留生育治疗(FST)对子宫内膜癌(EC)和非典型子宫内膜增生(AEH)患者的分子分型及其与临床病理因素和治疗效果的关系。方法:回顾性收集2020年6月至2022年12月北京大学人民医院接受FST和下一代测序分子分型检测的EC和AEH患者52例。结果(1)52例患者中,46例EC, 6例AEH, 42例(80.8%)在FST后达到完全缓解(CR),中位达到CR的时间为9个月。复发10例(23.8%)。(2)低拷贝数(CNL)患者39例(75%),微卫星不稳定-高拷贝数(MSI-H)患者7例(13.5%),极突变(POLEmut)患者4例(7.7%),高拷贝数(CNH)患者2例(3.8%)。MSI-H亚组患者肿瘤家族史较多(6/7),错配修复(MMR)蛋白表达缺失较多(7/7),Ki-67表达水平较高(3/3)。(3) MSI-H亚组患者在6个月时的CR率最低(0/7,P = 0.014),生存分析显示MSI-H亚组患者实现CR的可能性低于CNL患者(P = 0.022)。CNL患者6个月的中位CR率为40.6%。此外,3(3/4)例POLEmut患者和2(2/2)例CNH患者分别获得了CR。结论分子分型与接受FST治疗的EC和AEH患者的治疗反应有关。MSI-H亚组患者治疗效果较差,CNL患者需要进一步划分以预测治疗效果。在POLEmut和CNH亚群中也有一些成功的案例,需要进一步的研究。
{"title":"Characteristics of molecular classification in 52 endometrial cancer and atypical hyperplasia patients receiving fertility-sparing treatment","authors":"Yiqin Wang ,&nbsp;Nan Kang ,&nbsp;Liwei Li ,&nbsp;Zhiqi Wang ,&nbsp;Rong Zhou ,&nbsp;Danhua Shen ,&nbsp;Jianliu Wang","doi":"10.1016/j.gocm.2023.01.006","DOIUrl":"10.1016/j.gocm.2023.01.006","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the molecular classification of endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) patients treated with fertility-sparing treatment (FST), and its relationship with clinicopathological factors and treatment efficacy. Methods: A total of 52 ​EC and AEH patients who received FST and molecular classification tested by next generation sequencing in Peking University People's Hospital from June 2020 to December 2022, were retrospectively collected. We analyzed the relationship between molecular classification and clinicopathological factors and treatment outcomes.</p></div><div><h3>Results</h3><p>(1) Of the 52 patients, including 46 ​EC and 6 AEH patients, 42 (80.8%) achieved complete remission (CR) after FST, with a median time to achieve CR of 9 months. Ten cases (23.8%) had recurrence. (2) Patients were distributed into 4 molecular subgroups as 39 cases (75%) of copy number low (CNL) , 7 cases (13.5%) of microsatellite instability-high (MSI-H) , 4 cases (7.7%) of POLE mutations (POLEmut), and 2 cases (3.8%) of copy number high (CNH). Patients with MSI-H subgroup had more family history of tumor (6/7), more with loss of expression of mismatch repair (MMR) protein (7/7), and higher expression level of Ki-67 (3/3). (3) Patients with MSI-H subgroup had the lowest CR rate at 6 months (0/7, P ​= ​0.014), and survival analysis showed that such patients were less likely to achieve CR than those with CNL (P ​= ​0.022). For CNL patients, median 6-month CR rate was 40.6%. In addition, CR was obtained in 3 (3/4) POLEmut patients and 2 (2/2) CNH patients, respectively.</p></div><div><h3>Conclusions</h3><p>Molecular classification relates with the treatment response in patients with EC and AEH receiving FST. Patients with MSI-H subgroup have poor treatment efficacy, and patients with CNL need to be further divided to predict treatment benefit. There are also a few successful cases in POLEmut and CNH subtgroups, which needs further research.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 38-43"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46556976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urban-rural differences in the pregnancy-related adverse outcome 妊娠相关不良结局的城乡差异
Q4 Medicine Pub Date : 2023-03-01 DOI: 10.1016/j.gocm.2022.12.001
Vahid Mehrnoush , Amene Ranjbar , Farzaneh Banihashemi , Fatemeh Darsareh , Mitra Shekari , Malihe Shirzadfardjahromi

Background

Little is known about potential urban-rural differences in adverse pregnancy outcomes. The purpose of this study is to look into the urban-rural differences in the trend of adverse maternal and neonatal outcomes.

Methods

We retrospectively assessed the pregnancy outcome of singleton pregnant mothers who gave birth at a tertiary hospital in Bandar Abbas, Iran, between January 1st, 2020, and January 1st, 2022. Mothers were divided into two groups based on living residency: 1) urban groupand 2) rural group.Demographic factors, obstetrical factors, maternal comorbidities, and adverse maternal and neonatal outcomeswere extracted from the electronic data of each mother. The Chi-square testwas used to compare differences between the groups for categorical variables. Logistic regression models were used to assess the association of adverse pregnancy, childbirth, and neonatal outcome with living residency.

Results

Of 8888 mothers that gave birth during the study period, 2989 (33.6%) lived in rural areas. Adolescent pregnancy was more common in the rural area. Urban mothers had a higher education than rural mothers. Rural mothers were at higher risk for preterm birth aOR 1.81 (CI:1.24-2.99), post-term pregnancy aOR 1.5 (CI: 1.07-2.78), anemia aOR 2.02 (CI:1.07-2.34), low birth weight (LBW) aOR 1.89 (CI: 1.56-2.11), need for neonatal resuscitation aOR 2.66 (CI: 1.78-3.14), and neonatal intensive care unit (NICU) admission aOR 1.98 (CI:1.34-2.79). On the other hand, the risk of cesarean section was significantly lower compared to urban mothers aOR 0.58 (CI: 0.34-0.99).

Conclusions

Our study discovered that mothers living in rural areas had a higher risk of developing anemia, preterm birth, post-term pregnancies, LBW, need for neonatal resuscitation, and NICU admission, but a lower risk of cesarean section.

背景:对于不良妊娠结局的潜在城乡差异知之甚少。本研究的目的是探讨城乡之间孕产妇和新生儿不良结局趋势的差异。方法回顾性分析2020年1月1日至2022年1月1日在伊朗阿巴斯港某三级医院分娩的单胎孕妇的妊娠结局。母亲根据居住地分为两组:1)城市组和2)农村组。从每位母亲的电子数据中提取人口统计学因素、产科因素、孕产妇合并症以及孕产妇和新生儿不良结局。用卡方检验比较组间分类变量的差异。使用Logistic回归模型来评估不良妊娠、分娩和新生儿结局与居住住院的关系。结果研究期间分娩的8888名母亲中,2989名(33.6%)来自农村。青少年怀孕在农村地区更为普遍。城市母亲比农村母亲受教育程度更高。农村母亲早产风险较高,为1.81 (CI:1.24-2.99),足月妊娠风险为1.5 (CI: 1.07-2.78),贫血风险为2.02 (CI:1.07-2.34),低出生体重(LBW)风险为1.89 (CI: 1.56-2.11),需要新生儿复苏风险为2.66 (CI: 1.78-3.14),新生儿重症监护病房(NICU)入院风险为1.98 (CI:1.34-2.79)。另一方面,与城市母亲相比,剖宫产的风险显著降低(or 0.58) (CI: 0.34-0.99)。结论我们的研究发现,农村母亲发生贫血、早产、足月妊娠、LBW、需要新生儿复苏和入住新生儿重症监护病房的风险较高,但剖宫产的风险较低。
{"title":"Urban-rural differences in the pregnancy-related adverse outcome","authors":"Vahid Mehrnoush ,&nbsp;Amene Ranjbar ,&nbsp;Farzaneh Banihashemi ,&nbsp;Fatemeh Darsareh ,&nbsp;Mitra Shekari ,&nbsp;Malihe Shirzadfardjahromi","doi":"10.1016/j.gocm.2022.12.001","DOIUrl":"10.1016/j.gocm.2022.12.001","url":null,"abstract":"<div><h3>Background</h3><p>Little is known about potential urban-rural differences in adverse pregnancy outcomes. The purpose of this study is to look into the urban-rural differences in the trend of adverse maternal and neonatal outcomes.</p></div><div><h3>Methods</h3><p>We retrospectively assessed the pregnancy outcome of singleton pregnant mothers who gave birth at a tertiary hospital in Bandar Abbas, Iran, between January 1st, 2020, and January 1st, 2022. Mothers were divided into two groups based on living residency: 1) urban groupand 2) rural group.Demographic factors, obstetrical factors, maternal comorbidities, and adverse maternal and neonatal outcomeswere extracted from the electronic data of each mother. The Chi-square testwas used to compare differences between the groups for categorical variables. Logistic regression models were used to assess the association of adverse pregnancy, childbirth, and neonatal outcome with living residency.</p></div><div><h3>Results</h3><p>Of 8888 mothers that gave birth during the study period, 2989 (33.6%) lived in rural areas. Adolescent pregnancy was more common in the rural area. Urban mothers had a higher education than rural mothers. Rural mothers were at higher risk for preterm birth aOR 1.81 (CI:1.24-2.99), post-term pregnancy aOR 1.5 (CI: 1.07-2.78), anemia aOR 2.02 (CI:1.07-2.34), low birth weight (LBW) aOR 1.89 (CI: 1.56-2.11), need for neonatal resuscitation aOR 2.66 (CI: 1.78-3.14), and neonatal intensive care unit (NICU) admission aOR 1.98 (CI:1.34-2.79). On the other hand, the risk of cesarean section was significantly lower compared to urban mothers aOR 0.58 (CI: 0.34-0.99).</p></div><div><h3>Conclusions</h3><p>Our study discovered that mothers living in rural areas had a higher risk of developing anemia, preterm birth, post-term pregnancies, LBW, need for neonatal resuscitation, and NICU admission, but a lower risk of cesarean section.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"3 1","pages":"Pages 51-55"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43914961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovary syndrome 不同表型多囊卵巢综合征患者体重指数、抗苗勒激素和胰岛素抵抗参数的比较
Q4 Medicine Pub Date : 2022-12-01 DOI: 10.1016/j.gocm.2022.10.002
Türkan Gürsu , Alper Eraslan , Berk Angun

Background

Diagnosis of polycystic ovary syndrome (PCOS) depends on 2003 Rotterdam Criteria. According to these criteria there are four possible combinations resulting in various phenotypes. We aimed (i)to confirm that the levels of body mass index (BMI), anti-müllerian hormone (AMH) levels and insulin resistance (IR) are higher in PCOS patients and higher in phenotype-A among PCOS patients, and (ii)to determine cut-off values for the diagnosis of PCOS and phenotype-A.

Materials and methods

This study was conducted in an IVF Center, between November 2019 and January 2021. Data of infertile women participating in the study was evaluated retrospectively. Parameters such as menstruation pattern, clinical hyperandrogenism, age, BMI, follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, thyroid stimulating hormone (TSH), prolactin, AMH, dehydroepiandrosterone sulphate (DHEA-S), fasting blood glucose, fasting insulin levels, antral follicle counts (AFC) and ovarian volumes were recorded for each patient. Women were grouped as PCOS and non-PCOS, and PCOS group was further divided into 4 sub-groups according to their phenotypes. Data of infertile patients with PCOS patients were compared with infertile non-PCOS patients and PCOS phenotypes were compared among each other.

Results

Data of 244 infertile patients was included in the study. BMI, AMH, AFC, and HOMA-IR were statistically higher in PCOS patients, compared to non-PCOS patients. We found the AMH level of >3.105 ​ng/ml to be having 90.8% sensitivity and 90% specificity to diagnose a patient as PCOS. Among different phenotypes, also BMI, AMH, and insulin resistance index (HOMA-IR) levels were significantly higher in infertile PCOS phenotype-A when compared to other three phenotypes (p:0.003, p:0.000, and p:0.000, respectively). The AMH cut-off value to estimate phenotype-A was found as 6.095 ​ng/ml with 69.2% sensitivity and 86.7% specificity. We did not found threshold levels of BMI and HOMA-IR with high sensitivity to identify phenotype-A.

Conclusion

Properly diagnosing PCOS and determining the phenotype are crucial due to the long-term health conditions. Therefore, we suggest that serum AMH level could be included in PCOS diagnosis criteria, and the value of 3.105 ​ng/ml would have a 90.8% sensitivity and 90% specificity. Also, to identify phenotype-A, AMH level could be used. Therefore, we speculate that AMH may serve to identify PCOS and PCOS phenotype-A in places where ultrasound imaging is not straightforward to perform or not easily accessible.

背景多囊卵巢综合征(PCOS)的诊断取决于2003鹿特丹标准。根据这些标准,有四种可能的组合导致不同的表型。我们的目的是(1)确认PCOS患者的身体质量指数(BMI)、抗勒氏激素(AMH)水平和胰岛素抵抗(IR)水平较高,PCOS患者的a型表型较高,(2)确定PCOS和a型表型诊断的截止值。材料和方法本研究于2019年11月至2021年1月在IVF中心进行。对参与研究的不孕妇女的资料进行回顾性评价。记录每位患者的月经模式、临床高雄激素、年龄、BMI、促卵泡激素(FSH)、促黄体生成素(LH)、雌二醇、促甲状腺激素(TSH)、催乳素、AMH、硫酸脱氢表雄酮(DHEA-S)、空腹血糖、空腹胰岛素水平、窦室卵泡计数(AFC)、卵巢体积等参数。将女性分为PCOS和非PCOS两组,PCOS组根据其表型进一步分为4个亚组。将合并PCOS的不育患者与非PCOS的不育患者的数据进行比较,并相互比较PCOS的表型。结果244例不孕症患者资料纳入研究。与非PCOS患者相比,PCOS患者的BMI、AMH、AFC和HOMA-IR在统计学上更高。我们发现AMH水平为3.105 ng/ml,诊断PCOS的敏感性为90.8%,特异性为90%。在不同表型中,与其他三种表型相比,不育PCOS表型a的BMI、AMH和胰岛素抵抗指数(HOMA-IR)水平也显著高于其他三种表型(分别为p:0.003、p:0.000和p:0.000)。估计表型a的AMH临界值为6.095 ng/ml,敏感性为69.2%,特异性为86.7%。我们没有发现BMI和HOMA-IR具有高灵敏度的阈值水平来识别表型a。结论由于多囊卵巢综合征患者的长期健康状况,正确诊断多囊卵巢综合征并确定其表型至关重要。因此,我们建议将血清AMH水平纳入PCOS的诊断标准,3.105 ng/ml的值具有90.8%的敏感性和90%的特异性。此外,可以使用AMH水平来鉴定表型a。因此,我们推测AMH可能有助于在超声成像不直接或不容易获得的地方识别PCOS和PCOS表型- a。
{"title":"Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovary syndrome","authors":"Türkan Gürsu ,&nbsp;Alper Eraslan ,&nbsp;Berk Angun","doi":"10.1016/j.gocm.2022.10.002","DOIUrl":"10.1016/j.gocm.2022.10.002","url":null,"abstract":"<div><h3>Background</h3><p>Diagnosis of polycystic ovary syndrome (PCOS) depends on 2003 Rotterdam Criteria. According to these criteria there are four possible combinations resulting in various phenotypes. We aimed (i)to confirm that the levels of body mass index (BMI), anti-müllerian hormone (AMH) levels and insulin resistance (IR) are higher in PCOS patients and higher in phenotype-A among PCOS patients, and (ii)to determine cut-off values for the diagnosis of PCOS and phenotype-A.</p></div><div><h3>Materials and methods</h3><p>This study was conducted in an IVF Center, between November 2019 and January 2021. Data of infertile women participating in the study was evaluated retrospectively. Parameters such as menstruation pattern, clinical hyperandrogenism, age, BMI, follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, thyroid stimulating hormone (TSH), prolactin, AMH, dehydroepiandrosterone sulphate (DHEA-S), fasting blood glucose, fasting insulin levels, antral follicle counts (AFC) and ovarian volumes were recorded for each patient. Women were grouped as PCOS and non-PCOS, and PCOS group was further divided into 4 sub-groups according to their phenotypes. Data of infertile patients with PCOS patients were compared with infertile non-PCOS patients and PCOS phenotypes were compared among each other.</p></div><div><h3>Results</h3><p>Data of 244 infertile patients was included in the study. BMI, AMH, AFC, and HOMA-IR were statistically higher in PCOS patients, compared to non-PCOS patients. We found the AMH level of &gt;3.105 ​ng/ml to be having 90.8% sensitivity and 90% specificity to diagnose a patient as PCOS. Among different phenotypes, also BMI, AMH, and insulin resistance index (HOMA-IR) levels were significantly higher in infertile PCOS phenotype-A when compared to other three phenotypes (p:0.003, p:0.000, and p:0.000, respectively). The AMH cut-off value to estimate phenotype-A was found as 6.095 ​ng/ml with 69.2% sensitivity and 86.7% specificity. We did not found threshold levels of BMI and HOMA-IR with high sensitivity to identify phenotype-A.</p></div><div><h3>Conclusion</h3><p>Properly diagnosing PCOS and determining the phenotype are crucial due to the long-term health conditions. Therefore, we suggest that serum AMH level could be included in PCOS diagnosis criteria, and the value of 3.105 ​ng/ml would have a 90.8% sensitivity and 90% specificity. Also, to identify phenotype-A, AMH level could be used. Therefore, we speculate that AMH may serve to identify PCOS and PCOS phenotype-A in places where ultrasound imaging is not straightforward to perform or not easily accessible.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 4","pages":"Pages 164-170"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000884/pdfft?md5=fcab2ad18b741eb9f200f836039a2d67&pid=1-s2.0-S2667164622000884-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47113094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Gynecology and Obstetrics Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1